-
公开(公告)号:US07981930B2
公开(公告)日:2011-07-19
申请号:US12040856
申请日:2008-02-29
申请人: Jack Nguyen , Gregory T. Went , Paul Spence , Timothy J. Fultz , David Chernoff , Terry L. Burkoth , Rowan Chapman , Mickey S. Urdea
发明人: Jack Nguyen , Gregory T. Went , Paul Spence , Timothy J. Fultz , David Chernoff , Terry L. Burkoth , Rowan Chapman , Mickey S. Urdea
IPC分类号: A61K31/7056 , A61K31/351 , A61K31/215 , A61K31/196 , A61K31/195 , A61K31/131 , C07H19/056 , C07D309/28 , C07C69/75 , C07C61/22 , C07C229/48 , C07C211/38
CPC分类号: A61K31/454 , A61K31/7056 , A61K2300/00
摘要: Kits comprising an M2 inhibitor selected from amantadine and rimantadine; ribavirin, and a neuraminidase inhibitor (NAi) in an amount that is antivirally effective in the combination, an oral dosage form containing 75-250 mg of the M2 inhibitor, an oral dosage form comprising 100-400 mg of ribavirin and a neuraminidase inhibitor are provided for the treatment of influenza. Some embodiments of the kits comprise an oral dosage form containing 75-250 mg of the M2 inhibitor, an oral dosage form comprising 100-400 mg of ribavirin, and a neuraminidase inhibitor.
摘要翻译: 包含选自金刚胺和金刚乙胺的M2抑制剂的试剂盒; 利巴韦林和神经氨酸酶抑制剂(NAi),其组合中具有抗病毒效果的量,含有75-250mg的M2抑制剂的口服剂型,包含100-400mg的利巴韦林和神经氨酸酶抑制剂的口服剂型为 规定用于治疗流行性感冒。 试剂盒的一些实施方案包括含有75-250mg的M2抑制剂的口服剂型,包含100-400mg的利巴韦林的口服剂型和神经氨酸酶抑制剂。
-
公开(公告)号:US07858660B2
公开(公告)日:2010-12-28
申请号:US12477105
申请日:2009-06-02
申请人: Jack Nguyen , Gregory T. Went , Paul Spence , Timothy J. Fultz , David Chernoff , Terry L. Burkoth , Rowan Chapman , Mickey S. Urdea
发明人: Jack Nguyen , Gregory T. Went , Paul Spence , Timothy J. Fultz , David Chernoff , Terry L. Burkoth , Rowan Chapman , Mickey S. Urdea
IPC分类号: C07H19/056 , A61K31/215 , A61K31/166 , A61K31/16 , A61K31/7056 , A61K31/13 , C07D315/00 , C07D307/12 , C07C69/75 , C07C61/08 , C07C217/52
CPC分类号: A61K31/454 , A61K31/7056 , A61K2300/00
摘要: Compositions, kits and methods are provided for the treatment or prophylaxis of influenza.
摘要翻译: 提供组合物,试剂盒和方法用于治疗或预防流行性感冒。
-
公开(公告)号:US20090326978A1
公开(公告)日:2009-12-31
申请号:US12495793
申请日:2009-06-30
申请人: Timothy J. Fultz , Gregory T. Went , Jack Nguyen , Paul Spence , David Chernoff , Terry L. Burkoth , Rowan Chapman , Mickey S. Urdea
发明人: Timothy J. Fultz , Gregory T. Went , Jack Nguyen , Paul Spence , David Chernoff , Terry L. Burkoth , Rowan Chapman , Mickey S. Urdea
摘要: Stockpiles and methods of stockpiling a combination antiviral therapy for responding to an epidemic viral outbreak are described. Methods and systems of inventory control for co-deployment of drugs used in combination during a pandemic are described.
摘要翻译: 描述了储存组合抗病毒治疗以应对流行性病毒爆发的库存和方法。 描述了在大流行期间组合使用的药物共同部署的库存控制方法和系统。
-
公开(公告)号:US20090247481A1
公开(公告)日:2009-10-01
申请号:US12477105
申请日:2009-06-02
申请人: Jack Nguyen , Gregory T. Went , Paul Spence , Timothy J. Fultz , David Chernoff , Terry L. Burkoth , Rowan Chapman , Mickey S. Urdea
发明人: Jack Nguyen , Gregory T. Went , Paul Spence , Timothy J. Fultz , David Chernoff , Terry L. Burkoth , Rowan Chapman , Mickey S. Urdea
IPC分类号: A61K31/708
CPC分类号: A61K31/454 , A61K31/7056 , A61K2300/00
摘要: Compositions, kits and methods are provided for the treatment or prophylaxis of influenza.
摘要翻译: 提供组合物,试剂盒和方法用于治疗或预防流行性感冒。
-
公开(公告)号:US20080227743A1
公开(公告)日:2008-09-18
申请号:US12040856
申请日:2008-02-29
申请人: Jack Nguyen , Gregory T. Went , Paul Spence , Timothy J. Fultz , David Chernoff
发明人: Jack Nguyen , Gregory T. Went , Paul Spence , Timothy J. Fultz , David Chernoff
IPC分类号: A61K31/7056 , A61P31/12
CPC分类号: A61K31/454 , A61K31/7056 , A61K2300/00
摘要: Compositions, kits and methods are provided for the treatment or prophylaxis of influenza.
摘要翻译: 提供组合物,试剂盒和方法用于治疗或预防流行性感冒。
-
公开(公告)号:US20110230432A1
公开(公告)日:2011-09-22
申请号:US13116484
申请日:2011-05-26
申请人: Jack Nguyen , Gregory T. Went , Paul Spence , Timothy J. Fultz , David Chernoff
发明人: Jack Nguyen , Gregory T. Went , Paul Spence , Timothy J. Fultz , David Chernoff
IPC分类号: A61K31/7056 , A61P31/16
CPC分类号: A61K31/454 , A61K31/7056 , A61K2300/00
摘要: Compositions, kits and methods are provided for the treatment or prophylaxis of influenza.
摘要翻译: 提供组合物,试剂盒和方法用于治疗或预防流行性感冒。
-
公开(公告)号:US20080279819A1
公开(公告)日:2008-11-13
申请号:US11884516
申请日:2006-02-15
IPC分类号: A61K39/395 , A61K31/13 , A61K38/21 , A61K31/343 , A61K31/41 , A61P21/00 , A61P25/00 , A61P13/10 , A61P37/00 , A61K31/40 , A61K31/65 , A61K38/07
CPC分类号: A61K31/13 , A61K31/55 , A61K31/675 , A61K38/21 , A61K45/06 , A61K2300/00
摘要: The present invention provides novel methods and compositions for the treatment and prevention of demyelinating conditions. One demyelinating condition treated by the methods and compositions of the invention is multiple sclerosis. Also treated are symptoms associated with multiple sclerosis.
摘要翻译: 本发明提供了用于治疗和预防脱髓鞘病症的新颖方法和组合物。 通过本发明的方法和组合物治疗的一种脱髓鞘状态是多发性硬化。 还治疗是与多发性硬化相关的症状。
-
公开(公告)号:US20100160431A1
公开(公告)日:2010-06-24
申请号:US12545007
申请日:2009-08-20
申请人: Gregory Went , David Chernoff , Paul Spence , Terry Burkoth , Timothy Fultz
发明人: Gregory Went , David Chernoff , Paul Spence , Terry Burkoth , Timothy Fultz
IPC分类号: A61K31/215 , A61K31/13 , A61P31/16
CPC分类号: A61K45/06 , A61K9/2009 , A61K9/2054 , A61K9/2846 , A61K9/5026 , A61K9/5047 , A61K9/5073 , A61K9/5084 , A61K31/13 , A61K2300/00
摘要: Compositions for treating flu comprise an M2 inhibitor, and optionally a neuraminidase inhibitor, wherein at least one of said M2 inhibitor or said neuraminidase inhibitor is provided in an extended release dosage form.
摘要翻译: 用于治疗流感的组合物包含M2抑制剂和任选的神经氨酸酶抑制剂,其中所述M2抑制剂或所述神经氨酸酶抑制剂中的至少一种以延长释放剂型形式提供。
-
公开(公告)号:US20070270443A1
公开(公告)日:2007-11-22
申请号:US11804753
申请日:2007-05-18
申请人: Gregory Went , David Chernoff , Paul Spence , Terry Burkoth , Timothy Fultz
发明人: Gregory Went , David Chernoff , Paul Spence , Terry Burkoth , Timothy Fultz
IPC分类号: A61K31/522 , A61K31/13
CPC分类号: A61K45/06 , A61K9/2009 , A61K9/2054 , A61K9/2846 , A61K9/5026 , A61K9/5047 , A61K9/5073 , A61K9/5084 , A61K31/13 , A61K2300/00
摘要: Compositions for treating flu comprise an M2 inhibitor, and optionally a neuraminidase inhibitor, wherein at least one of said M2 inhibitor or said neuraminidase inhibitor is provided in an extended release dosage form.
摘要翻译: 用于治疗流感的组合物包含M2抑制剂和任选的神经氨酸酶抑制剂,其中所述M2抑制剂或所述神经氨酸酶抑制剂中的至少一种以延长释放剂型形式提供。
-
-
-
-
-
-
-
-